Mefenamic Acid
(mef'' e nam' ik as' id).
Click to View Image
C15H15NO2 241.29

Benzoic acid, 2-(2,3-dimethylphenyl)amino-.
N-2,3-Xylylanthranilic acid [61-68-7].
» Mefenamic Acid contains not less than 98.0 percent and not more than 102.0 percent of C15H15NO2, calculated on the dried basis.
Packaging and storage— Preserve in tight, light-resistant containers.
USP Reference standards 11
USP Mefenamic Acid RS Click to View Structure
Identification—
B: The retention time of the major peak in the chromatogram of the Assay preparation corresponds to that in the chromatogram of the Standard preparation, as obtained in the Assay.
Loss on drying 731 Dry it at 105 for 4 hours: it loses not more than 1.0% of its weight.
Residue on ignition 281: not more than 0.1%.
Chromatographic purity—
Buffer solution, Mobile phase, and Chromatographic system—Proceed as directed in the Assay.
Standard solution— Dissolve an accurately weighed quantity of USP Mefenamic Acid RS in Mobile phase to obtain a solution having a known concentration of about 10 µg per mL.
Test solution— Transfer about 100 mg of Mefenamic Acid, accurately weighed, to a 100-mL volumetric flask, dissolve in and dilute with Mobile phase to volume, and mix.
Procedure— Separately inject equal volumes (about 10 µL) of the Standard solution and the Test solution into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the percentage of each impurity in the portion of Mefenamic Acid taken by the formula:
100(CS / CU)(ri / rS)
in which CS is the concentration, in µg per mL, of USP Mefenamic Acid RS in the Standard solution; CU is the concentration, in µg per mL, of Mefenamic Acid in the Test solution; ri is the peak response for each impurity obtained from the Test solution; and rS is the peak response for mefenamic acid obtained from the Standard solution: not more than 0.1% of any individual impurity is found; and not more than 0.5% of total impurities is found.
Assay—
Buffer solution— Prepare a 50 mM solution of monobasic ammonium phosphate, and adjust with 3 M ammonium hydroxide to a pH of 5.0.
Mobile phase— Prepare a filtered and degassed mixture of acetonitrile, Buffer solution, and tetrahydrofuran (23:20:7). Make adjustments if necessary (see System Suitability under Chromatography 621).
Standard preparation— Dissolve an accurately weighed quantity of USP Mefenamic Acid RS in Mobile phase, and dilute quantitatively, and stepwise if necessary, with Mobile phase to obtain a solution having a known concentration of about 0.2 mg per mL.
Assay preparation— Transfer about 100 mg of Mefenamic Acid, accurately weighed, to a 500-mL volumetric flask, dissolve in and dilute with Mobile phase to volume, and mix.
Chromatographic system (see Chromatography 621)—The liquid chromatograph is equipped with a 254-nm detector and a 4.6-mm × 25-cm column that contains packing L1. The flow rate is about 1 mL per minute. Chromatograph the Standard preparation, and record the peak responses as directed for Procedure: the column efficiency is not less than 8200 theoretical plates; the tailing factor for the analyte peak is not more than 1.6; and the relative standard deviation for replicate injections is not more than 1.0%.
Procedure— Separately inject equal volumes (about 10 µL) of the Standard preparation and the Assay preparation into the chromatograph, record the chromatograms, and measure the responses for the major peaks. Calculate the quantity, in mg, of C15H15NO2 in the portion of Mefenamic Acid taken by the formula:
500C(rU / rS)
in which C is the concentration, in mg per mL, of USP Mefenamic Acid RS in the Standard preparation; and rU and rS are the mefenamic acid peak responses obtained from the Assay preparation and the Standard preparation, respectively.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Clydewyn M. Anthony, Ph.D.
Senior Scientific Liaison
1-301-816-8139
(SM22010) Monographs - Small Molecules 2
Reference Standards RS Technical Services
1-301-816-8129
rstech@usp.org
USP35–NF30 Page 3782
Pharmacopeial Forum: Volume No. 34(2) Page 281